Suckers. Regardless of what happens to Moderna, the patent holders working at NIAID et al will still collect royalties from the patented tech used in other mRNA vaccines- like Pfizer- well into the future. That's where the money and motive lies. They DGAF what happens to Moderna, it was just a pay-to-plague ship.
That is massive selling, by major players. Would be interesting to know who is buying from them.
Suckers. Regardless of what happens to Moderna, the patent holders working at NIAID et al will still collect royalties from the patented tech used in other mRNA vaccines- like Pfizer- well into the future. That's where the money and motive lies. They DGAF what happens to Moderna, it was just a pay-to-plague ship.